Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pfisterer

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Circulation|September 1, 2004
Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)Matthias Pfisterer,
Lancet (London, England)|August 9, 2003
Right ventricular involvement in myocardial infarction and cardiogenic shockMatthias Pfisterer
American Heart Journal|October 31, 2006
Anemia as independent predictor of major events in elderly patients with chronic anginaStefano Muzzarelli, Matthias Pfisterer,
European Heart Journal|February 19, 2014
Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?Matthias Pfisterer, Christoph Kaiser
Herz|July 4, 2007
[Increased rate of stent thrombosis with DES]Christoph Kaiser, Matthias Pfisterer
Circulation|December 20, 2011
No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantationMatthias Pfisterer, Christoph Kaiser, Raban Jeger
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsMatthias Pfisterer, Christoph Kaiser, Raban Jeger
Evidence-Based Cardiovascular Medicine|March 15, 2006
Paclitaxel-eluting stents appear to reduce revascularisation in people with long lesionsChristoph Kaiser, Matthias Pfisterer, Debbie Singh
Expert Review of Cardiovascular Therapy|October 22, 2013
Long-term safety of drug-eluting stentsFlorian N Riede, Matthias Pfisterer, Raban Jeger
Swiss Medical Weekly|September 2, 2011
Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET). A review of the BASKET trialsMatthias Pfisterer, Fabian Nietlispach, Raban Jeger, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Circulation|September 1, 2004
Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)Matthias Pfisterer,
Lancet (London, England)|August 9, 2003
Right ventricular involvement in myocardial infarction and cardiogenic shockMatthias Pfisterer
American Heart Journal|October 31, 2006
Anemia as independent predictor of major events in elderly patients with chronic anginaStefano Muzzarelli, Matthias Pfisterer,
European Heart Journal|February 19, 2014
Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?Matthias Pfisterer, Christoph Kaiser
Herz|July 4, 2007
[Increased rate of stent thrombosis with DES]Christoph Kaiser, Matthias Pfisterer
Circulation|December 20, 2011
No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantationMatthias Pfisterer, Christoph Kaiser, Raban Jeger
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsMatthias Pfisterer, Christoph Kaiser, Raban Jeger
Evidence-Based Cardiovascular Medicine|March 15, 2006
Paclitaxel-eluting stents appear to reduce revascularisation in people with long lesionsChristoph Kaiser, Matthias Pfisterer, Debbie Singh
Expert Review of Cardiovascular Therapy|October 22, 2013
Long-term safety of drug-eluting stentsFlorian N Riede, Matthias Pfisterer, Raban Jeger
Swiss Medical Weekly|September 2, 2011
Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET). A review of the BASKET trialsMatthias Pfisterer, Fabian Nietlispach, Raban Jeger, et al.
Pageof 9